BPG is committed to discovery and dissemination of knowledge
Randomized Controlled Trial
Copyright: ©Author(s) 2026.
World J Gastrointest Surg. May 27, 2026; 18(5): 115612
Published online May 27, 2026. doi: 10.4240/wjgs.v18.i5.115612
Table 1 Comparison of baseline characteristics between the control group and the observation group, n (%)/mean ± SD
Characteristic
Control group (n = 90)
Observation group (n = 90)
P value
Sex
Male58 (64.4)56 (62.2)0.120
Female32 (35.6)34 (37.8)
Age (years)
Range60-8261-83
68.59 ± 5.2369.21 ± 5.560.082
Etiology of cirrhosis
Hepatitis B38 (42.2)36 (40.0)0.921
Hepatitis C12 (13.3)14 (15.6)
Alcoholic liver disease25 (27.8)23 (25.6)
Others15 (16.7)17 (18.9)
Severity of bleeding
Mild (< 500 mL)28 (31.1)30 (33.3)0.381
Moderate (500-1000 mL)42 (46.7)40 (44.4)
Severe (> 1000 mL)20 (22.2)20 (22.2)
Child-Pugh classification
Grade A22 (24.4)24 (26.7)0.743
Grade B45 (50.0)43 (47.8)
Grade C23 (25.6)23 (25.6)
Comorbidities
Hypertension38 (42.2)40 (44.4)0.234
Diabetes mellitus21 (23.3)19 (21.1)
Table 2 Comparison of core indicators of agitation behavior changes between the two groups, mean ± SD
GroupnCohen-Mansfield Agitation Inventory score
Mean number of episodes per day (times/day)
Duration of once (minutes)
Before
After
Before
After
Before
After
Control9069.20 ± 8.1253.89 ± 6.734.21 ± 0.823.32 ± 0.7628.57 ± 6.3220.17 ± 4.52
Observation9070.89 ± 9.1042.56 ± 5.254.15 ± 0.901.85 ± 0.5327.90 ± 6.1510.27 ± 2.82
t value1.31512.5930.46815.0510.72117.629
P value0.1900.0000.6410.0000.4720.000
Table 3 Comparison of neuroendocrine and inflammatory index changes in two groups, mean ± SD
Group
n
Cortisol (μg/dL)
Norepinephrine (pg/mL)
Interleukin-6 (pg/mL)
Tumor necrosis factor alpha (pg/mL)
Before
After
Before
After
Before
After
Before
After
Control9022.42 ± 5.1118.56 ± 4.13842.46 ± 156.67678.69 ± 134.2589.36 ± 20.1261.21 ± 14.3545.67 ± 10.2932.67 ± 7.83
Observation9022.15 ± 4.9214.36 ± 3.22835.89 ± 162.23436.78 ± 98.1088.76 ± 21.3732.52 ± 8.7644.85 ± 11.1218.32 ± 5.16
t value0.3617.6080.27613.8020.19416.1890.51314.518
P value0.7180.0000.7830.0000.8460.0000.6080.000
Table 4 Comparison of clinical complications and outcomes between the two groups, n (%)
Group
n
Re-bleeding
Aspiration
Unplanned extubation
Change over to intensive care unit
Death
Control901510133311
Observation90634185
χ² value4.367--6.156-
P value0.0370.0810.0390.0130.189
Odds ratio2.8003.6253.6302.3162.367
95%CI1.033-7.5880.963-13.6501.135-11.6101.183-4.5320.787-7.117
Table 5 Analysis of intervention module contributions to improving agitated behavior in the observation group
Intervention module
β
t value
P value
Contribution ratio (%)
Individualized psychological intervention compliance0.3825.217< 0.00142.3
Effective rate of pain management0.2964.053< 0.00132.7
Time spent with family0.1852.6410.00320.5
Implementation of environmental optimization0.0971.5620.121-
Communication and coordination guidance success rate0.0821.3840.168-
Table 6 Comparison of subjective experience scores between two patient groups and their families (points), mean ± SD
Group
n
Safety rating
Communication satisfaction
Humanistic care perception
Total points
Control826.21 ± 1.355.89 ± 1.425.67 ± 1.5317.77 ± 3.86
Observation868.53 ± 0.988.72 ± 0.858.91 ± 0.7626.16 ± 2.13
t value12.79015.75817.50517.550
P value0.0000.0000.0000.000


Write to the Help Desk